TickerFactsScreenerDevelopers

Aprea Therapeutics, Inc. (APRE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: -$21.47M2017: -$35.77M2018: -$51.44M2019: $124.24M2020: $77.40M2021: $49.51M2022: $25.64M2023: $16.95M2024: $19.31M2025: $12.44M$12.44M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$12.44M-35.6%
2024$19.31M+13.9%
2023$16.95M-33.9%
2022$25.64M-48.2%
2021$49.51M-36.0%
2020$77.40M-37.7%
2019$124.24M+341.5%
2018-$51.44M-43.8%
2017-$35.77M-66.6%
2016-$21.47M—